UK-based EKF Diagnostics will launch two new diagnostic tests, a new assay for early sepsis detection and a hand-held point of care haemoglobin analyser at Medica 2014.
Medica 2014 will be held from 12-15 November in Düsseldorf, Germany.
The new CE Marked liquicolor procalcitonin (PCT) liquid-stable assay will be used on automatic chemistry analysers as an early and specific indicator of sepsis.
The PCT can be used to quickly evaluate the initial severity of sepsis, since procalcitonin levels elevate during systemic bacterial infection and sepsis.
Available in a liquid stable format, the new liquicolor PCT immunoturbidimetric assay can remain stable on-board a clinical chemistry analyser for four weeks, and requires a minimal sample of 20µl.
According to the company, this assay also improves laboratory workflow as it can be run on a primary chemistry analyser and eliminate the need to split a sample.
A new version of its Hemo Control haemoglobin analyser, the Biosen glucose and lactate analyser will be exhibited by the company, and includes the preview of SensPoint, a new lactate analyser designed for use in professional medical settings.
The company will also exhibit the new which can be used in all climate conditions.
DiaSpect uses reagent-free microcuvettes, which have a shelf-life of two and a half years, and can be stored from 0°-50°C.
The company said that DiaSpect is portable and lightweight and holds a long battery life for 40 days of continuous use, or 10,000 tests, due to its integrated rechargeable lithium-ion battery.
DiaSpect is factory calibrated against the HiCN reference method in accordance with International Council for Standardization in Haematology (ICSH) and requires no re-calibration or maintenance, as it undertakes an automatic self-check between every measurement.
Image: EKF DiaSpect Tm hemoglobin analyzer. Photo: courtesy of EKF Diagnostics.